Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.

Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, Richie JP, Langer R.

Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6315-20. Epub 2006 Apr 10.

PMID:
16606824
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Nanoparticle-aptamer bioconjugates for cancer targeting.

Farokhzad OC, Karp JM, Langer R.

Expert Opin Drug Deliv. 2006 May;3(3):311-24. Review.

PMID:
16640493
[PubMed - indexed for MEDLINE]
3.

Aptamer-dendrimer bioconjugate: a nanotool for therapeutics, diagnosis, and imaging.

Pednekar PP, Jadhav KR, Kadam VJ.

Expert Opin Drug Deliv. 2012 Oct;9(10):1273-88. Epub 2012 Aug 16. Review.

PMID:
22897588
[PubMed - indexed for MEDLINE]
4.

Cell-specific aptamer-mediated targeted drug delivery.

Zhou J, Rossi JJ.

Oligonucleotides. 2011 Feb;21(1):1-10. doi: 10.1089/oli.2010.0264. Epub 2010 Dec 23. Review.

PMID:
21182455
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Tumor-targeting drug delivery of new-generation taxoids.

Ojima I, Zuniga ES, Berger WT, Seitz JD.

Future Med Chem. 2012 Jan;4(1):33-50. doi: 10.4155/fmc.11.167. Review.

PMID:
22168163
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk